Produkt
KlappentextWhile bone density scans (DXA) play a vital role, managing osteoporosis requires a broader perspective. DXA focuses solely on bone mineral density, neglecting crucial factors like bone microarchitecture and quality. These influence fracture risk, especially for those with seemingly normal density (osteopenia).This gap necessitates a multifaceted approach. New diagnostic tools like high-resolution peripheral QCT offer a deeper look at bone structure. Additionally, blood tests for specific markers can shed light on bone turnover and future fracture risk.Integrating these advancements with traditional DXA and a thorough risk factor assessment (age, family history, medications) creates a personalized approach. This allows healthcare professionals to identify individuals at high risk, even with normal bone density, enabling earlier intervention. Beyond diagnosis, a multipronged strategy encompassing nutrition, exercise, and medications is crucial for promoting bone health and preventing fractures. This comprehensive approach paves the way for a healthier future for those susceptible to osteoporosis.
